Company / Current Assets per Share
Jazz Pharmaceuticals Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$68.71
FY2025
5-year range
$42.28 / $74.36
FY2021-FY2025
Trend
-7.6%
vs FY2024
Sector context
#6 of 210
Health Care
What the data says
Among 210 Health Care companies, Jazz Pharmaceuticals is in the top 3% for current assets per share. Current Assets per Share has fluctuated over the past 10 years, ranging from $12.20 in FY2016 to $74.36 in FY2024.
Based on SEC 10-K filings.
68.71 in FY2025 with a 5-year CAGR of +6.3%. Top quartile in the Health Care sector.
Improved from $54.35 to $68.71 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +17.6%
- 5-Year CAGR
- +6.3%
- 10-Year CAGR
- -
Sector benchmark
-48.9% below sector average
Key checks
Key Insights
- In FY2025, current assets per share decreased 7.6% year-over-year.
- Ranks #6 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2024.
- Lowest current assets per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.66 (distress zone, below 1.8 threshold)
- Negative profit margin: -8.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $68.71 | -7.6% |
| FY2024 | $74.36 | +36.8% |
| FY2023 | $54.35 | +28.5% |
| FY2022 | $42.28 | -9.0% |
| FY2021 | $46.49 | -8.1% |
| FY2020 | $50.58 | +79.0% |
| FY2019 | $28.25 | +34.8% |
| FY2018 | $20.95 | +29.4% |
| FY2017 | $16.19 | +32.7% |
| FY2016 | $12.20 | -41.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026